MyOme’s Post

Last week, our CEO, Premal Shah, Ph.D. attended the launch of the Catalyst SR program! The Lieutenant Governor of Alabama, Will Ainsworth, announced the beginning of this program that will be available to patients and providers across the state of Alabama. The entire state’s population will be able to use MyOme’s Proactive Health reports to develop personalized treatment plans to help prevent disease. “By providing a single sample, these patients and their providers will have access to MyOme’s industry-leading, genetics-driven clinical reports including a proactive screen for rare, single-gene alterations, a pharmacogenomics report measuring response to over 70 common medications, and our integrated PRS reports for coronary artery disease, type 2 diabetes, and breast cancer.” - Premal Shah, Ph.D.

The MyOme team is thrilled to support this important initiative alongside Broad Clinical Labs and Southern Research. This GenomeWeb article demonstrates the use of an innovative technology blended-genome sequencing (a combined strategy for doing low-pass whole-genome sequencing and deep-coverage whole-exome) sequencing to provide free genetic testing for all Alabamians. https://lnkd.in/givPz9UZ #genome #genetictesting #sequencing #populationhealth #preventativehealth #preventative #screening #catalyst #myome

🚀 Exciting news! MyOme and Broad Clinical Labs are joining forces with Southern Research in support of their Catalyst Program to bring FREE genetics-driven health insights to Alabamians state-wide! 🧬✨ This initiative empowers underserved communities with personalized health assessments using MyOme’s Proactive Health Screen that includes single gene analysis, pharmacogenomics, and PRS reports for common diseases. “Providing these patients and their providers with personalized health insights using MyOme's industry-leading, clinical risk assessments will allow providers to identify potentially life-saving interventions, lifestyle and medication changes, imaging, and early cancer detection tests for their patients." - Josh Carpenter, President and CEO of Southern Research Learn more in this PR here: https://lnkd.in/gyvCF4Yt #Genetics #HealthEquity #AlabamaHealth #CollaborationForHealth #GenomicsInHealthcare #WGS #GeneticScreening #GeneticTesting #MyOme #Exome #Genome

🎉 Congratulations Matthew Rabinowitz, PhD, executive chairman and co-founder at MyOme, for being named a finalist in the Leadership category for the California Life Sciences (CLS) Annual Pantheon Awards! This recognition follows his recent honor as R&D Leader of the Year by R&D World. Matt's contributions to the biotech industry are invaluable, and we are continually inspired by your vision and leadership. Public voting is open until October 15th! Cast your vote here: https://ow.ly/TRKX50TBIYj #CLS #rd100 #rdworld #rd #myome #natera #populationhealth #pgx #phr #screening

🎉 Congratulations Matthew Rabinowitz, PhD, the chairman of MyOme's board and one of our co-founders, for being selected as R&D - Research & Development World’s “R&D Leader of the Year”!  Matt, we’re grateful for the vision and inspiration you continuously share with us and with the industry as a whole. Cheers! 🎉 #rd100 #rdworld #rd #myome #natera #populationhealth #pgx #phr #screening #diagnotictesting #precisiononcology #wgs #genome #genetics #genomesequencing #wholegenomesequencing #healthtech #healthcare #health #precisionmedicine #precisionhealth #genes #science #dna #dnasequencing #dnatesting #dnatest #biotech #familyhealth #hereditarycancer #cancer #pharmacogenetics #pharmacogenomics #familymedicine #conciergemedicine https://lnkd.in/gyWPnAcJ